Cognition Therapeutics, Inc. (CGTX) - Quarterly Income Statement

Home
CGTX
Financials

2.61 (USD) • At close September 5, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0.25	0	0	0	0.372	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0.061	0.045	0.071	0.07	0.067	0.058	0.066	0.065	0.061	0.06	0.06	0.06	0.059	0.056	0.023	0.023	0.024	0.023	0	0	0	0
Gross Profit Numbers are in millions	-0.061	-0.045	-0.071	-0.07	-0.067	-0.058	0.306	-0.065	-0.061	-0.06	-0.06	-0.06	-0.059	-0.056	-0.023	-0.023	-0.024	-0.023	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	-0.284	0	0	0	0.823	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	11.481	10.786	8.154	11.392	11.577	10.553	11.6	11.669	8.497	5.43	6.44	8.268	9.098	6.518	5.573	3.675	4.894	4.43	3.287	3.399	2.755	3.446
General & Administrative Expenses Numbers are in millions	2.497	2.989	2.569	3.071	3.101	3.549	3.589	3.076	3.32	3.543	2.86	4.357	3.115	2.895	6.235	1.548	1.09	1.153	0.833	1.062	1.18	1.445
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	-0.058	-0.066	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	2.497	2.989	2.569	3.071	3.101	3.491	3.523	3.076	3.32	3.543	2.86	4.357	3.115	2.895	6.235	1.548	1.09	1.153	0.833	1.062	1.18	1.445
Other Expenses Numbers are in millions	0	0	-0.071	0	0	0	0	0	0.172	-3.426	-3.981	-5.947	-0.042	-5.904	-0.604	-0.924	-0.941	0.145	0.129	0.095	0.116	0.142
Operating Expenses Numbers are in millions	13.978	13.775	10.652	14.463	14.678	14.044	15.123	14.745	4.892	5.547	5.319	6.678	5.828	3.509	6.736	2.186	1.338	0.891	1.411	1.269	1.254	2.618
Operating Income Numbers are in millions	-13.978	-13.775	-10.723	-14.463	-14.678	-14.102	-15.189	-14.745	-11.817	-8.973	-9.3	-12.625	-12.213	-9.413	-11.808	-5.223	-5.984	-5.583	-4.12	-4.461	-3.935	-4.891
Operating Income Ratio Numbers are in millions	0	0	-42.892	0	0	0	-40.831	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0	5.295	2.881	4.526	7.637	4.951	7.048	7.996	7.091	2.801	4.118	6	6.336	5.7	4.469	2.113	4.494	5.806	2.252	2.67	2.261	2.385
Income Before Tax Numbers are in millions	-6.734	-8.48	-7.842	-9.937	-7.041	-9.151	-8.141	-6.749	-4.726	-6.172	-5.182	-6.625	-5.877	-3.713	-7.339	-3.11	-1.49	0.223	-1.868	-1.791	-1.674	-2.506
Income Before Tax Ratio Numbers are in millions	0	0	-31.368	0	0	0	-21.884	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	0	0	0	0	0	0	-2.791	-16.154	-6	-0.125	0.125	0	0	0	0	0	0	0	0
Net Income Numbers are in millions	-6.734	-8.48	-7.842	-9.937	-7.041	-9.151	-8.141	-6.749	-4.726	-3.381	10.972	-0.625	-5.752	-3.838	-7.339	-3.11	-1.49	0.223	-1.868	-1.791	-1.674	-2.506
Net Income Ratio Numbers are in millions	0	0	-31.368	0	0	0	-21.884	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.11	-0.14	-0.17	-0.25	-0.18	-0.27	-0.26	-0.22	-0.16	-0.12	0.38	-0.027	-0.25	-0.17	-0.35	-0.15	-0.071	0.01	-0.089	-0.084	-0.077	-0.12
EPS Diluted Numbers are in millions	-0.11	-0.14	-0.17	-0.25	-0.18	-0.27	-0.26	-0.22	-0.16	-0.12	0.38	-0.027	-0.25	-0.17	-0.35	-0.15	-0.071	0.01	-0.089	-0.084	-0.077	-0.12
EBITDA Numbers are in millions	-13.978	-13.775	-7.766	-9.864	-6.967	-9.083	-8.066	-6.682	-4.659	-6.102	-5.112	-6.563	-5.811	-3.648	-7.317	-3.087	-1.109	0.783	-4.096	-1.261	-1.209	-2.205
EBITDA Ratio Numbers are in millions	0	0	-31.064	0	0	0	-21.683	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cognition Therapeutics, Inc.

NASDAQ:CGTX Add to watchlist

NASDAQ:CGTX